Guillermo de Velasco, Academic Medical Oncologist at Hospital 12 de Octubre, shared OncoSur Foundation‘s post on X, adding:
“What is BRCA and why does it matter in prostate cancer?
Because these mutations not only increase the risk, they also change the way it’s treated.
María José Juan Fita explains it.”
Quoting OncoSur Foundation’s post:
“The EmpowerGU project is back.
5 specialized professionals answer the questions you always had about the treatment of genitourinary cancers.
Proceed to the video attached to the post.
More posts featuring Guillermo de Velasco.
